Pharmacyclics (PCYC) Tops Q1 EPS by 32c, Revenue Misses
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other (expense) income, net: 285K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Pharmacyclics (NASDAQ: PCYC) reported Q1 EPS of $0.43, $0.32 better than the analyst estimate of $0.11. Revenue for the quarter came in at $206 million versus the consensus estimate of $226.27 million.
For earnings history and earnings-related data on Pharmacyclics (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
